Bioventus Ratios (2020-2026) | BVS

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Apr2021 Jul2021 Oct2021 Dec2021 Apr2022 Jul2022 Oct2022 Dec2022 Apr2023 Jul2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter)
69.49%72.61%67.30%64.54%68.88%65.70%58.96%62.09%65.02%65.28%63.73%68.27%68.54%67.32%66.82%67.05%69.14%67.96%68.89%68.72%
EBT Margin (Quarter)
-8.26%-2.89%-2.11%-16.66%-4.62%-101.47%-25.78%-84.13%-3.17%-6.78%-6.21%-4.23%-27.48%-3.78%-0.03%-2.76%6.98%3.37%8.96%3.42%
EBIT Margin (Quarter)
-5.23%-0.96%-2.42%-18.29%-2.36%-98.58%-12.43%-77.32%4.92%2.00%0.86%3.81%-20.81%2.62%5.01%3.93%12.44%8.12%12.34%6.37%
EBITDA Margin (Quarter)
-3.74%-2.42%6.03%-9.73%-5.87%-79.09%-26.95%-116.44%-3.23%-6.27%-5.29%-5.38%-17.21%-3.79%-2.83%-1.72%7.36%1.94%10.92%2.63%
Operating Margin (Quarter)
-5.23%-0.96%-2.42%-18.29%-2.36%-98.58%-12.43%-77.32%4.92%2.00%0.86%3.81%-20.81%2.62%5.01%3.93%12.44%8.12%12.34%6.37%
Net Margin (Quarter)
-9.82%-2.08%-0.02%-0.34%-0.20%-34.71%-18.59%-62.51%-2.68%6.28%2.89%10.97%2.99%
FCF Margin (Quarter)
14.62%11.59%0.16%-20.44%0.65%-1.16%9.28%-0.90%6.86%-2.06%3.19%-4.86%10.08%7.49%11.99%-15.72%16.64%22.64%24.03%6.36%
Efficiency
Inventory Average (Quarter)
36.91M35.29M49.13M63.19M66.88M73.02M80.86M86.36M92.11M96.92M94.45M94.17M92.31M88.82M91.25M93.26M95.25M96.37M89.25M82.71M
Assets Average (Quarter)
644.86M650.71M940.33M1,211.50M1,202.96M1,303.40M1,385.34M1,130.03M862.18M824.03M811.01M802.57M793.21M780.83M748.72M709.68M699.10M704.19M692.58M667.05M
Equity Average (Quarter)
219.82M185.93M380.08M600.73M592.94M521.56M431.63M326.29M236.85M229.90M223.79M219.28M203.25M187.95M186.22M185.54M193.39M183.70M197.27M208.67M
Invested Capital (Quarter)
234.36M167.50M965.34M614.10M614.63M482.34M828.81M281.68M612.23M606.07M600.96M593.67M557.34M555.42M521.23M521.41M537.54M497.13M522.40M460.98M
Asset Utilization Ratio (Quarter)
0.580.610.460.380.410.400.370.450.590.610.630.650.680.710.770.800.810.800.820.86
Leverage & Solvency
Debt to Equity (Quarter)
0.831.160.590.620.630.941.011.851.651.741.661.801.921.951.771.721.701.941.291.44
Debt Ratio (Quarter)
0.280.270.290.310.310.300.300.500.460.490.450.490.460.470.450.460.480.460.430.42
Equity Ratio (Quarter)
0.340.230.500.500.490.320.300.270.280.280.270.270.240.240.250.270.280.240.330.29
Valuation
Enterprise Value (Quarter)
-62.26M-52.92M91.47M39.49M31.21M1.37M56.77M4.75M20.76M22.10M10.56M20.98M6.13M-4.98M-3.92M14.53M7.15M-1.00M-6.90M9.52M
Return Ratios
Return on Sales (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Capital Employed (Quarter)
5.98%4.31%1.59%-3.02%-2.88%-15.25%-15.47%-25.47%-33.35%-14.86%-12.86%2.43%-4.09%-3.82%-2.82%-2.85%6.74%7.78%10.14%11.08%
Return on Invested Capital (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%